Rasagiline
- Product NDC
- 80005-141
- 11-digit product format
- 800050141
- Labeler code
- 80005
- Product ID
- 80005-141_0be04379-452a-455f-8df6-bd319391580a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Carnegie Pharmaceuticals LLC
- Application
- ANDA201942
- Marketing category
- ANDA
- Marketing start
- 2026-01-15
- Substance
- RASAGILINE MESYLATE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rasagiline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RASAGILINE MESYLATE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LH8C2JI290 |
| Rxcui | 608328, 636664 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 80005-141-08 | Rasagiline | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 80005-141-10 | Rasagiline | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
| 80005-141-14 | Rasagiline | 500 in 1 BOTTLE | TABLET | 500 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 80005-141-08 | 80005014108 | 30 TABLET in 1 BOTTLE (80005-141-08) | 30 tablet | 2026-01-15 | No | No | Current |
| 80005-141-10 | 80005014110 | 90 TABLET in 1 BOTTLE (80005-141-10) | 90 tablet | 2026-01-15 | No | No | Current |
| 80005-141-14 | 80005014114 | 500 TABLET in 1 BOTTLE (80005-141-14) | 500 tablet | 2026-01-15 | No | No | Current |